Inventor · disambiguated record
Christian Scheffold
Also filed as: SCHEFFOLD CHRISTIAN
2 granted patents·5 pending applications·9 citations·filing 2017–2023
55Inventor score
Technology areasA61K
Files withEXELIXIS INC7
Top patents by PatentIndex Score
7 records- 0190US11141413B2Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioateEXELIXIS INC·Filed 2017·Granted Oct 12, 2021·8 cites·21 claims
- 0277US2024350477A1Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioateEXELIXIS INC·Filed 2023·Application pending·0 cites
- 0376US11198731B2Combinations of cabozantinib and atezolizumab to treat cancerEXELIXIS INC·Filed 2018·Granted Dec 14, 2021·1 cites·17 claims
- 0473US2022401433A1Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioateEXELIXIS INC·Filed 2022·Application pending·0 cites
- 0569US2023045783A9Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioateEXELIXIS INC·Filed 2021·Application pending·0 cites
- 0660US2022056138A1Combinations of Cabozantinib and Atezolizumab to Treat CancerEXELIXIS INC·Filed 2021·Application pending·0 cites
- 0753US2023301979A1Combinations for the treatment of cancerEXELIXIS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christian Scheffold files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →